Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor

Biochemical Journal

Volumn 357, Issue 3, 2001, Pages 859-865

  Raggers, R J ^a   Vogels, I ^a   Van Meer, G ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Apical membrane; Epithelial cells; Ether lipid; Inflammatory response; Lipid mediator; Lipid translocator

Indexed keywords

ACYLATION; BIOLOGICAL MEMBRANES; CONCENTRATION (PROCESS); LIPIDS; TUMORS;

HUMAN MULTIDRUG RESISTANCE;

BIOCHEMISTRY;

CYCLOSPORIN A; GLYCOPROTEIN P; INDOMETACIN; THROMBOCYTE ACTIVATING FACTOR; VALSPODAR;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL MEMBRANE; CONTROLLED STUDY; KIDNEY CELL; LIPID TRANSPORT; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SWINE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CELLS, CULTURED; CYCLOSPORINS; GLYCERYL ETHERS; HUMANS; P-GLYCOPROTEIN; PHOSPHATIDYLCHOLINES; PLATELET ACTIVATING FACTOR; SERUM ALBUMIN, BOVINE; SWINE; TRANSFECTION;

EID: 0035425507     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3570859     Document Type: Article

References (47)

1. ABC transporters: From microorganisms to man
2. Is the multidrug transporter a flippase?
3. Overexpression of the Multidrug Resistance-associated Protein (MRP) increases resistance to natural product drugs
4. MDR3 P-grycoprotein, a phosphatidylchotine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping
5. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice
6. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
7. Phosphatidylcholine translocase: A physiological role for the mdr2 gene
8. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
9. Lipid traffic: The ABC of transbilayer movement
10. Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein
11. The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane
12. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: Outward-directed transport by the multidrug resistance protein 1 (MRP1)
13. Multidrug resistance protein 1 regulates lipid asymmetry in erythrocyte membranes
14. Secretion of platelet-activating factor is mediated by MDR1 P-glycoprotein in cultured human mesangial cells
15. Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils
16. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine
17. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex
18. Release of platelet activating factor in rabbits with antibody-mediated injury of the lung: The role of leukocytes and of pulmonary endothelial cells
19. The presence of platelet-activating factor (PAF) in normal human mixed saliva
20. Identification of phospholipid platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid and urine
21. Potential angiogenic role of platelet-activating factor in human breast cancer
22. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure
23. Platelet-activating factor and related lipid mediators
24. Conversion of alkylacetylglycerol to platelet-activating factor in HL-60 cells and subcellular localization of the mediator
25. The final step in the de novo biosynthesis of platelet-activating factor. Properties of a unique CDP-choline: 1-alkyl-2-acetyl-sn-glycerol choline-phosphotransferase in microsomes from the renal inner medulla of rats
26. Subcellular localization of phospholipids and enzymes involved in PAF-acether metabolism
27. Absence of the mdna P-glycoprotein in mice affects tissue distribution and pharmokinetics of dexamethasone, digoxin, and cyclosporin A
28. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells
29. Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase
30. Sphingomyelin transport to the cell surface occurs independently of protein secretion in rat hepatocytes
31. Sorting of newly synthesized galactosphingolipids to the two surface domains of epithelial cells
32. Conversion of diacylglycerol to phosphatidylcholine on the basolateral surface of epithelial (Madin-Darby canine kidney) cells. Evidence for the reverse action of a sphingomyelin synthase
33. Release of platelet activation factor from activated neutrophils. Transglutaminase-dependent enhancement of transbilayer movement across the plasma membrane
34. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833
35. Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin
36. Brefeldin A: Insights into the control of membrane traffic and organelle structure
37. Transport of sphingomyelin to the cell surface is inhibited by brefeldin A and in mitosis, where C6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity
38. PAF-acetylhydrolases
39. The release of platelet-activating factor from human endothelial cells in culture
40. Fast translocation of phosphatidylcholine to the outer membrane leaflet after its synthesis at the inner membrane surface in human erythrocytes
41. Transbilayer movement of various phosphatidylcholine species in intact human erythrocytes
42. Transbilayer reorientation of platelet-activating factor in the erythrocyte membrane
43. Polarized release of lipid mediators derived from phospholipase A2 activity in a human bronchial cell line
44. A novel model of inflammatory bowel disease: Mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis
45. Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells
46. Phosphorylation site mutations in the human multidrug transporter modulate its drug-stimulated ATPase activity
47. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin